Sean Saint, the President & CEO of $BBNX, sold 5,641 shares of the company on 09-03-2026 for an estimated $113,258. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.4% of their shares of this class of stock. Following this trade, they now own 398,429 shares of this class of $BBNX stock.
$BBNX Insider Trading Activity
$BBNX insiders have traded $BBNX stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $BBNX stock by insiders over the last 6 months:
- SEAN SAINT (President & CEO) has made 0 purchases and 3 sales selling 39,380 shares for an estimated $648,346.
- STEPHEN FEIDER (Chief Financial Officer) has made 0 purchases and 4 sales selling 23,351 shares for an estimated $382,132.
- MARK HOPMAN (Chief Commercial Officer) has made 0 purchases and 4 sales selling 12,189 shares for an estimated $191,264.
- MIKE MENSINGER (Chief Product Officer) has made 0 purchases and 2 sales selling 8,753 shares for an estimated $138,813.
- STEVEN JON RUSSELL (Chief Medical Officer) has made 0 purchases and 2 sales selling 8,443 shares for an estimated $133,903.
- CHRISTY JONES has made 0 purchases and 3 sales selling 6,215 shares for an estimated $80,324.
- ADAM LEZACK has made 0 purchases and 2 sales selling 1,998 shares for an estimated $21,137.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$BBNX Hedge Fund Activity
We have seen 90 institutional investors add shares of $BBNX stock to their portfolio, and 93 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DIVISADERO STREET CAPITAL MANAGEMENT, LP added 1,113,802 shares (+inf%) to their portfolio in Q2 2026, for an estimated $17,453,277
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 956,784 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $9,586,975
- FARALLON CAPITAL MANAGEMENT LLC removed 706,000 shares (-16.4%) from their portfolio in Q1 2026, for an estimated $7,074,120
- JPMORGAN CHASE & CO added 703,356 shares (+inf%) to their portfolio in Q2 2026, for an estimated $11,021,588
- WALLEYE CAPITAL LLC removed 646,539 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $6,478,320
- VESTAL POINT CAPITAL, LP removed 611,518 shares (-27.7%) from their portfolio in Q2 2026, for an estimated $9,582,487
- 12 WEST CAPITAL MANAGEMENT LP removed 575,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $5,761,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$BBNX Revenue
$BBNX had revenues of $32M in Q2 2026. This is an increase of 37.76% from the same period in the prior year.
You can track BBNX financials on Quiver Quantitative's BBNX stock page.
You can access data on BBNX stock through the Quiver Quantitative API.
$BBNX Price Targets
Multiple analysts have issued price targets for $BBNX recently. We have seen 5 analysts offer price targets for $BBNX in the last 6 months, with a median target of $18.0.
Here are some recent targets:
- David Roman from Goldman Sachs set a target price of $17.0 on 05/27/2026
- Travis Steed from B of A Securities set a target price of $11.0 on 05/18/2026
- Mike Kratky from Leerink Partners set a target price of $24.0 on 04/22/2026
- Jonathan Block from Stifel set a target price of $20.0 on 04/22/2026
- Richard Newitter from Truist Securities set a target price of $18.0 on 04/15/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
